PRESS RELEASE published on 08/19/2023 at 01:55, 3 years 2 months ago Empower Clinics Provides Corporate Update
PRESS RELEASE published on 08/15/2023 at 14:30, 3 years 2 months ago Empower Clinics Announces Closing of Second Tranche Private Placement Financing
PRESS RELEASE published on 08/09/2023 at 12:30, 3 years 2 months ago Empower Clinics Announces Closing of First Tranche Private Placement Financing
PRESS RELEASE published on 08/01/2023 at 12:30, 3 years 2 months ago Empower Clinics Announces Proposal For Division Spin Out
PRESS RELEASE published on 07/31/2023 at 12:30, 3 years 2 months ago Empower Clinics Signs New Agreements To Advance Growth Of Research and Clinical Trials with Signing Of Two Additional Principal Investigators - And Are Approved To Process Multiple Clinical Study Applications From Pharmaceutical Sponsors
PRESS RELEASE published on 06/23/2023 at 12:30, 3 years 3 months ago Empower Clinics Announces Proposed Private Placement
PRESS RELEASE published on 06/19/2023 at 12:30, 3 years 4 months ago Empower Clinics Announces Share Consolidation
PRESS RELEASE published on 06/06/2023 at 12:30, 3 years 4 months ago Empower Clinics Signs Letter of Intent for $5 Million Equity Capital Facility and Provides Additional Corporate Updates
PRESS RELEASE published on 05/19/2023 at 22:45, 3 years 4 months ago Empower Clinics Provides Corporate Update
PRESS RELEASE published on 05/09/2023 at 12:30, 3 years 5 months ago Empower Clinics Provides Corporate Update
Published on 10/19/2026 at 14:30, 7 hours 31 minutes ago Core Silver Intersects Copper Bearing VMS Mineralization at the Touleary Project
Published on 10/19/2026 at 14:00, 8 hours 1 minute ago Four Nines Gold Intersects 80.1 Meters Averaging 1.08 g/t Gold in Expanding Lower Telegraph Corridor at Hayden Hill
Published on 10/19/2026 at 13:30, 8 hours 31 minutes ago Empress Announces Closing of Tongon Gold Stream Investment and Debt Financing
Published on 10/19/2026 at 13:30, 8 hours 31 minutes ago Mako Mining Announces Q3 2026 Production Results with Gold Recovered of 12,743 oz Au (Sales of 11,581 oz Au), and Positive Permitting Updates at Mt. Hamilton and San Albino
Published on 10/19/2026 at 13:01, 9 hours ago CoTec Holdings Corp. Notes HyProMag USA Deployment of Mobile Inserma System, Extending Hard Disk Drive Processing to Customer Sites Across the United States
Published on 10/19/2026 at 21:22, 39 minutes ago EQS-Adhoc: Cantourage Group SE: Supervisory Board Resolves to Transition to IFRS Following First-Time Requirement to Prepare Consolidated Financial Statements
Published on 10/19/2026 at 19:00, 3 hours 1 minute ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 12/10/2026 au 16/10/2026
Published on 10/19/2026 at 18:05, 3 hours 56 minutes ago Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Published on 10/19/2026 at 17:45, 4 hours 16 minutes ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Published on 10/19/2026 at 17:45, 4 hours 16 minutes ago VALBIOTIS SA: Valbiotis doublement récompensé « Meilleur Produit Pharma 2027 » pour ses solutions ValbiotisPRO® Cholestérol et ValbiotisPRO® Santé Métabolique
Published on 10/19/2026 at 19:00, 3 hours 1 minute ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 : Compte rendu et résultat des votes - Évolution de la gouvernance
Published on 10/19/2026 at 18:40, 3 hours 21 minutes ago Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:40, 3 hours 21 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 12 et 13 octobre 2026
Published on 10/19/2026 at 18:00, 4 hours 1 minute ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 18:00, 4 hours 1 minute ago L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola